FDA reviews new painkiller

Share this article:

The FDA is set to review another drug that could join the prescription painkiller mix today. NPR reports that the latest pain reliever combines morphine and oxycodone. The all-in-one medication called Moxduo would be the first to combine the two pain relievers.

COO of drugmaker QRXPharma Ed Rudnic tells NPR that patients end up taking less of each drug with this medication than they would if prescribed both separately.

Painkillers have become a hot topic among lawmakers and addiction specialists because of a rise in opioid abuse. Massachusetts recently tried to ban opioid Zohydro in an effort to curb opioid abuse, but a court found the ban was unconstitutional.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.